178 related articles for article (PubMed ID: 17668284)
1. The T963C mutation of TP53 gene does not participate in the clonal origin of canine TVT.
Vázquez-Mota N; Simón-Martínez J; Córdova-Alarcon E; Lagunes L; Fajardo R
Vet Res Commun; 2008 Feb; 32(2):187-91. PubMed ID: 17668284
[TBL] [Abstract][Full Text] [Related]
2. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
[TBL] [Abstract][Full Text] [Related]
3. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
Bautista-Gómez L; Martínez-Castañeda S
Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
[TBL] [Abstract][Full Text] [Related]
4. Analysis of canine transmissible veneral tumor genotypes using the D-loop region of mitochondrial DNA.
Bautista-Gómez LG; Martínez-Castañeda S; Córdova-Alarcón E; Vázquez-Chagoyán JC
Genes Genet Syst; 2011; 86(5):351-5. PubMed ID: 22362033
[TBL] [Abstract][Full Text] [Related]
5. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of canine LINE-1 elements and p53 gene in canine transmissible venereal tumor.
Choi YK; Kim CJ
J Vet Sci; 2002 Dec; 3(4):285-92. PubMed ID: 12825561
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer.
Strakova A; Ní Leathlobhair M; Wang GD; Yin TT; Airikkala-Otter I; Allen JL; Allum KM; Bansse-Issa L; Bisson JL; Castillo Domracheva A; de Castro KF; Corrigan AM; Cran HR; Crawford JT; Cutter SM; Delgadillo Keenan L; Donelan EM; Faramade IA; Flores Reynoso E; Fotopoulou E; Fruean SN; Gallardo-Arrieta F; Glebova O; Häfelin Manrique RF; Henriques JJ; Ignatenko N; Koenig D; Lanza-Perea M; Lobetti R; Lopez Quintana AM; Losfelt T; Marino G; Martincorena I; Martínez Castañeda S; Martínez-López MF; Meyer M; Nakanwagi B; De Nardi AB; Neunzig W; Nixon SJ; Onsare MM; Ortega-Pacheco A; Peleteiro MC; Pye RJ; Reece JF; Rojas Gutierrez J; Sadia H; Schmeling SK; Shamanova O; Ssuna RK; Steenland-Smit AE; Svitich A; Thoya Ngoka I; Vițălaru BA; de Vos AP; de Vos JP; Walkinton O; Wedge DC; Wehrle-Martinez AS; van der Wel MG; Widdowson SA; Murchison EP
Elife; 2016 May; 5():. PubMed ID: 27185408
[TBL] [Abstract][Full Text] [Related]
8. Detection of the tumour suppressor gene TP53 and expression of p53, Bcl-2 and p63 proteins in canine transmissible venereal tumour.
Stockmann D; Ferrari HF; Andrade AL; Cardoso TC; Luvizotto MC
Vet Comp Oncol; 2011 Dec; 9(4):251-9. PubMed ID: 22077405
[TBL] [Abstract][Full Text] [Related]
9. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis.
Thomas R; Rebbeck C; Leroi AM; Burt A; Breen M
Chromosome Res; 2009; 17(7):927-34. PubMed ID: 19798471
[TBL] [Abstract][Full Text] [Related]
10. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis.
Setthawongsin C; Techangamsuwan S; Tangkawattana S; Rungsipipat A
J Vet Med Sci; 2016 Aug; 78(7):1167-73. PubMed ID: 27075116
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
[TBL] [Abstract][Full Text] [Related]
12. Clonal origin and evolution of a transmissible cancer.
Murgia C; Pritchard JK; Kim SY; Fassati A; Weiss RA
Cell; 2006 Aug; 126(3):477-87. PubMed ID: 16901782
[TBL] [Abstract][Full Text] [Related]
13. Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.
Murchison EP; Wedge DC; Alexandrov LB; Fu B; Martincorena I; Ning Z; Tubio JMC; Werner EI; Allen J; De Nardi AB; Donelan EM; Marino G; Fassati A; Campbell PJ; Yang F; Burt A; Weiss RA; Stratton MR
Science; 2014 Jan; 343(6169):437-440. PubMed ID: 24458646
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial capture by a transmissible cancer.
Rebbeck CA; Leroi AM; Burt A
Science; 2011 Jan; 331(6015):303. PubMed ID: 21252340
[TBL] [Abstract][Full Text] [Related]
15. Comparison against 186 canid whole-genome sequences reveals survival strategies of an ancient clonally transmissible canine tumor.
Decker B; Davis BW; Rimbault M; Long AH; Karlins E; Jagannathan V; Reiman R; Parker HG; Drögemüller C; Corneveaux JJ; Chapman ES; Trent JM; Leeb T; Huentelman MJ; Wayne RK; Karyadi DM; Ostrander EA
Genome Res; 2015 Nov; 25(11):1646-55. PubMed ID: 26232412
[TBL] [Abstract][Full Text] [Related]
16. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
[TBL] [Abstract][Full Text] [Related]
17. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
18. Canine transmissible venereal tumor - From general to molecular characteristics: A review.
Faro TAS; de Oliveira EHC
Anim Genet; 2023 Feb; 54(1):82-89. PubMed ID: 36259378
[TBL] [Abstract][Full Text] [Related]
19. Recurrent horizontal transfer identifies mitochondrial positive selection in a transmissible cancer.
Strakova A; Nicholls TJ; Baez-Ortega A; Ní Leathlobhair M; Sampson AT; Hughes K; Bolton IAG; Gori K; Wang J; Airikkala-Otter I; Allen JL; Allum KM; Arnold CL; Bansse-Issa L; Bhutia TN; Bisson JL; Blank K; Briceño C; Castillo Domracheva A; Corrigan AM; Cran HR; Crawford JT; Cutter SM; Davis E; de Castro KF; De Nardi AB; de Vos AP; Delgadillo Keenan L; Donelan EM; Espinoza Huerta AR; Faramade IA; Fazil M; Fotopoulou E; Fruean SN; Gallardo-Arrieta F; Glebova O; Gouletsou PG; Häfelin Manrique RF; Henriques JJGP; Horta RS; Ignatenko N; Kane Y; King C; Koenig D; Krupa A; Kruzeniski SJ; Lanza-Perea M; Lazyan M; Lopez Quintana AM; Losfelt T; Marino G; Martínez Castañeda S; Martínez-López MF; Masuruli BM; Meyer M; Migneco EJ; Nakanwagi B; Neal KB; Neunzig W; Nixon SJ; Ortega-Pacheco A; Pedraza-Ordoñez F; Peleteiro MC; Polak K; Pye RJ; Ramirez-Ante JC; Reece JF; Rojas Gutierrez J; Sadia H; Schmeling SK; Shamanova O; Sherlock AG; Steenland-Smit AE; Svitich A; Tapia Martínez LJ; Thoya Ngoka I; Torres CG; Tudor EM; van der Wel MG; Vițălaru BA; Vural SA; Walkinton O; Wehrle-Martinez AS; Widdowson SAE; Zvarich I; Chinnery PF; Falkenberg M; Gustafsson CM; Murchison EP
Nat Commun; 2020 Jun; 11(1):3059. PubMed ID: 32546718
[TBL] [Abstract][Full Text] [Related]
20. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
